Little, Mark P.
National Cancer Institute (NCI),
United States
2025 Rank: 32629
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Nuclear Medicine & Medical Imaging
Rank in SubField 1: 976 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 32629 | 22458 |
| Total Cites | 879 | 1146 |
| H-index | 13 | 13 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 41 | 41 |
| Total Cites to Single Authored Papers | 35 | 44 |
| Number of Single+First Authored Papers | 174 | 174 |
| Total Cites to Single+First Authored Papers | 258 | 400 |
| Number of Single+First+Last Authored Papers | 202 | 202 |
| Total Cites to Single+First+Last Authored Papers | 330 | 490 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 695 | 731 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.57 |
| Self-Citation Percentage |
23.30%
|
|
Little, Mark P.
National Cancer Institute (NCI),
United States
2024 Rank: 27156
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Nuclear Medicine & Medical Imaging
Rank in SubField 1: 872 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 27156 | 21530 |
| Total Cites | 876 | 1064 |
| H-index | 13 | 14 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 42 | 42 |
| Total Cites to Single Authored Papers | 42 | 47 |
| Number of Single+First Authored Papers | 170 | 170 |
| Total Cites to Single+First Authored Papers | 274 | 360 |
| Number of Single+First+Last Authored Papers | 197 | 197 |
| Total Cites to Single+First+Last Authored Papers | 347 | 443 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 627 | 662 |
| Ratio of Total Citations to Distinct Citing Papers | 1.40 | 1.61 |
| Self-Citation Percentage |
17.67%
|
|
Little, Mark P.
National Cancer Institute (NCI),
United States
2023 Rank: 28041
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Nuclear Medicine & Medical Imaging
Rank in SubField 1: 991 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 28041 | 21091 |
| Total Cites | 940 | 1165 |
| H-index | 13 | 14 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 42 | 42 |
| Total Cites to Single Authored Papers | 50 | 55 |
| Number of Single+First Authored Papers | 166 | 166 |
| Total Cites to Single+First Authored Papers | 241 | 327 |
| Number of Single+First+Last Authored Papers | 193 | 193 |
| Total Cites to Single+First+Last Authored Papers | 339 | 446 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 727 | 763 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.53 |
| Self-Citation Percentage |
19.31%
|
|
Little, Mark P.
National Cancer Institute (NCI),
United States
2022 Rank: 22625
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Nuclear Medicine & Medical Imaging
Rank in SubField 1: 844 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 22625 | 16756 |
| Total Cites | 976 | 1245 |
| H-index | 12 | 14 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 42 | 42 |
| Total Cites to Single Authored Papers | 52 | 63 |
| Number of Single+First Authored Papers | 158 | 158 |
| Total Cites to Single+First Authored Papers | 257 | 349 |
| Number of Single+First+Last Authored Papers | 183 | 183 |
| Total Cites to Single+First+Last Authored Papers | 357 | 479 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 769 | 823 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.51 |
| Self-Citation Percentage |
21.61%
|
|
Little, Mark P.
National Cancer Institute (NCI),
United States
2021 Rank: 24384
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Nuclear Medicine & Medical Imaging
Rank in SubField 1: 890 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 24384 | 17515 |
| Total Cites | 1418 | 1767 |
| H-index | 15 | 17 |
| Hm-index | 7 | 9 |
| Number of Single Authored Papers | 41 | 41 |
| Total Cites to Single Authored Papers | 69 | 87 |
| Number of Single+First Authored Papers | 148 | 148 |
| Total Cites to Single+First Authored Papers | 331 | 459 |
| Number of Single+First+Last Authored Papers | 171 | 171 |
| Total Cites to Single+First+Last Authored Papers | 472 | 642 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1142 | 1227 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.44 |
| Self-Citation Percentage |
19.75%
|
|
Little, Mark P.
National Cancer Institute,
United States
2020 Rank: 24332
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Nuclear Medicine & Medical Imaging
Rank in SubField 1: 859 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 24332 | 24064 |
| Total Cites | 1032 | 1181 |
| H-index | 14 | 14 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 41 | 41 |
| Total Cites to Single Authored Papers | 57 | 60 |
| Number of Single+First Authored Papers | 145 | 145 |
| Total Cites to Single+First Authored Papers | 246 | 282 |
| Number of Single+First+Last Authored Papers | 166 | 166 |
| Total Cites to Single+First+Last Authored Papers | 338 | 392 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 872 | 933 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.27 |
| Self-Citation Percentage |
12.62%
|
|